223 related articles for article (PubMed ID: 19060417)
1. Importance of Rac1 signaling pathway inhibition in the pleiotropic effects of HMG-CoA reductase inhibitors.
Rashid M; Tawara S; Fukumoto Y; Seto M; Yano K; Shimokawa H
Circ J; 2009 Feb; 73(2):361-70. PubMed ID: 19060417
[TBL] [Abstract][Full Text] [Related]
2. Statins exert the pleiotropic effects through small GTP-binding protein dissociation stimulator upregulation with a resultant Rac1 degradation.
Tanaka S; Fukumoto Y; Nochioka K; Minami T; Kudo S; Shiba N; Takai Y; Williams CL; Liao JK; Shimokawa H
Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1591-600. PubMed ID: 23640485
[TBL] [Abstract][Full Text] [Related]
3. Impact of HMG CoA reductase inhibition on small GTPases in the heart.
Laufs U; Kilter H; Konkol C; Wassmann S; Böhm M; Nickenig G
Cardiovasc Res; 2002 Mar; 53(4):911-20. PubMed ID: 11922901
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase.
Wassmann S; Laufs U; Bäumer AT; Müller K; Konkol C; Sauer H; Böhm M; Nickenig G
Mol Pharmacol; 2001 Mar; 59(3):646-54. PubMed ID: 11179461
[TBL] [Abstract][Full Text] [Related]
5. HMG-CoA reductase inhibitors up-regulate anti-aging klotho mRNA via RhoA inactivation in IMCD3 cells.
Narumiya H; Sasaki S; Kuwahara N; Irie H; Kusaba T; Kameyama H; Tamagaki K; Hatta T; Takeda K; Matsubara H
Cardiovasc Res; 2004 Nov; 64(2):331-6. PubMed ID: 15485693
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of RhoA or Rac1? Mechanism of cholesterol-independent beneficial effects of statins.
Rikitake Y; Hirata K
Circ J; 2009 Feb; 73(2):231-2. PubMed ID: 19164861
[No Abstract] [Full Text] [Related]
7. Inhibition of serotonin-induced mitogenesis, migration, and ERK MAPK nuclear translocation in vascular smooth muscle cells by atorvastatin.
Li M; Liu Y; Dutt P; Fanburg BL; Toksoz D
Am J Physiol Lung Cell Mol Physiol; 2007 Aug; 293(2):L463-71. PubMed ID: 17545489
[TBL] [Abstract][Full Text] [Related]
8. 3-hydroxy-3-methylglutaryl coenzyme A reductase-independent inhibition of CD40 expression by atorvastatin in human endothelial cells.
Wagner AH; Gebauer M; Güldenzoph B; Hecker M
Arterioscler Thromb Vasc Biol; 2002 Nov; 22(11):1784-9. PubMed ID: 12426205
[TBL] [Abstract][Full Text] [Related]
9. Effects of atorvastatin and pravastatin on signal transduction related to glucose uptake in 3T3L1 adipocytes.
Takaguri A; Satoh K; Itagaki M; Tokumitsu Y; Ichihara K
J Pharmacol Sci; 2008 May; 107(1):80-9. PubMed ID: 18469500
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy with atorvastatin and amlodipine suppresses angiotensin II-induced aortic aneurysm formation.
Takahashi K; Matsumoto Y; Do e Z; Kanazawa M; Satoh K; Shimizu T; Sato A; Fukumoto Y; Shimokawa H
PLoS One; 2013; 8(8):e72558. PubMed ID: 23967318
[TBL] [Abstract][Full Text] [Related]
11. HMG-CoA reductase inhibitors decrease angiotensin II-induced vascular fibrosis: role of RhoA/ROCK and MAPK pathways.
Rupérez M; Rodrigues-Díez R; Blanco-Colio LM; Sánchez-López E; Rodríguez-Vita J; Esteban V; Carvajal G; Plaza JJ; Egido J; Ruiz-Ortega M
Hypertension; 2007 Aug; 50(2):377-83. PubMed ID: 17592071
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological modulation of epithelial mesenchymal transition caused by angiotensin II. Role of ROCK and MAPK pathways.
Rodrigues-Díez R; Carvajal-González G; Sánchez-López E; Rodríguez-Vita J; Rodrigues Díez R; Selgas R; Ortiz A; Egido J; Mezzano S; Ruiz-Ortega M
Pharm Res; 2008 Oct; 25(10):2447-61. PubMed ID: 18633694
[TBL] [Abstract][Full Text] [Related]
13. The protective effect of HMG-CoA reductase inhibitors against monocrotaline-induced pulmonary hypertension in the rat might not be a class effect: comparison of pravastatin and atorvastatin.
Rakotoniaina Z; Guerard P; Lirussi F; Goirand F; Rochette L; Dumas M; Bardou M
Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec; 374(3):195-206. PubMed ID: 17102939
[TBL] [Abstract][Full Text] [Related]
14. Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation.
Wagner AH; Köhler T; Rückschloss U; Just I; Hecker M
Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):61-9. PubMed ID: 10634801
[TBL] [Abstract][Full Text] [Related]
15. Atorvastatin but not elocalcitol increases sildenafil responsiveness in spontaneously hypertensive rats by regulating the RhoA/ROCK pathway.
Fibbi B; Morelli A; Marini M; Zhang XH; Mancina R; Vignozzi L; Filippi S; Chavalmane A; Silvestrini E; Colli E; Adorini L; Vannelli GB; Maggi M
J Androl; 2008; 29(1):70-84. PubMed ID: 17699803
[TBL] [Abstract][Full Text] [Related]
16. Atorvastatin prevents angiotensin II-induced high permeability of human arterial endothelial cell monolayers via ROCK signaling pathway.
Yi R; Xiao-Ping G; Hui L
Biochem Biophys Res Commun; 2015 Mar; 459(1):94-9. PubMed ID: 25712521
[TBL] [Abstract][Full Text] [Related]
17. Involvement of Rho-kinase in experimental vascular endothelial dysfunction.
Shah DI; Singh M
Mol Cell Biochem; 2006 Feb; 283(1-2):191-9. PubMed ID: 16444602
[TBL] [Abstract][Full Text] [Related]
18. Statins stimulate in vitro membrane FasL expression and lymphocyte apoptosis through RhoA/ROCK pathway in murine melanoma cells.
Sarrabayrouse G; Synaeve C; Leveque K; Favre G; Tilkin-Mariamé AF
Neoplasia; 2007 Dec; 9(12):1078-90. PubMed ID: 18084615
[TBL] [Abstract][Full Text] [Related]
19. Atorvastatin and pitavastatin enhance lipoprotein lipase production in L6 skeletal muscle cells through activation of adenosine monophosphate-activated protein kinase.
Ohira M; Endo K; Saiki A; Miyashita Y; Terai K; Murano T; Watanabe F; Tatsuno I; Shirai K
Metabolism; 2012 Oct; 61(10):1452-60. PubMed ID: 22520230
[TBL] [Abstract][Full Text] [Related]
20. Atorvastatin ameliorates sildenafil-induced penile erections in experimental diabetes by inhibiting diabetes-induced RhoA/Rho-kinase signaling hyperactivation.
Morelli A; Chavalmane AK; Filippi S; Fibbi B; Silvestrini E; Sarchielli E; Zhang XH; Vignozzi L; Vannelli GB; Forti G; Maggi M
J Sex Med; 2009 Jan; 6(1):91-106. PubMed ID: 19170840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]